Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print January 15, 2008
DOI: 10.2337/db07-0226

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0226v1
57/4/918    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsui, H.
Right arrow Articles by Dosch, H.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsui, H.
Right arrow Articles by Dosch, H.-M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Targeting of Pancreatic Glia in Type 1 Diabetes

Hubert Tsui, Ph.D1, Yin Chan, B.Sc1, Lan Tang, MD1, Shawn Winer, MD1, Roy K. Cheung, M.Sc1, Geoffrey Paltser, B.Sc1, Thirumahal Selvanantham, B.Sc1, Alisha R. Elford, B.Sc2, James R. Ellis, Ph.D1, Dorothy J. Becker, MD2, Pamela S. Ohashi, Ph.D3, and Hans-Michael Dosch, MD1

1Research Institute, The Hospital for Sick Children, Departments of Pediatrics, Immunology and Genetics, University of Toronto, Toronto, ON, M5G 1X8, Canada
2Department of Pediatrics, Children's Hospital and University of Pittsburgh, Pittsburgh, PA, USA
3The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Departments of Medical Biophysics and Immunology, University of Toronto, Toronto, ON, M5G 2C1, Canada

Objective: Type 1 Diabetes (T1D) reflects autoimmune-destruction of β-cells and peri-islet Schwann cells (pSC) but the mechanisms of pSC death and the T cell epitopes involved remain unclear.

Research Design And Methods: Primary pSC cultures were generated and used as targets in CTL assays in NOD mice. Cognate interaction between pSC and CD8+ T cells was assessed by transgenic restoration of β2-microglobulin (β 2m) to pSC in NOD.β 2m–/– congenics. I-Ag7 and Kd epitopes in the pSC antigen GFAP were identified by peptide mapping or algorithms, respectively and the latter tested by immunotherapy.

Results: pSC cultures did not express MHC class II and were lysed by ex vivo CTLs from diabetic NOD mice. In vivo, restoration of MHC class I in GFAP-β 2M transgenics significantly accelerated adoptively transferred diabetes. Target epitopes in the pSC autoantigen GFAP were mapped to residues 79-87 and 253-261 for Kd and 96-110, 116-130 and 216-230 for I-Ag7. These peptides were recognized spontaneously in NOD spleens as early as 2.5 wk of age, with proliferative responses peaking around weaning and detectable life-long. Several were also recognized by T cells from new-onset T1D patients. NOD mouse immunotherapy at 8 wk with the CD8+ T cell epitope, GFAP79-87 but not 253-261, significantly inhibited T1D and was associated with reduced IFN-{gamma} production to whole protein GFAP.

Conclusions: Collectively, these findings elucidate a role for pSC specific CD8+ T cells in islet inflammation and T1D pathogenesis, further supporting neuronal involvement in β-cell demise.


Correspondence: hmdosch{at}sickkids.ca


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.